Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Drug targets in Candida albicans

Drug targets in Candida albicans

US Patent 7125970 · Granted Oct 24, 2006

Estimated economic value: $162,105,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HPK1 inhibitors2025
Bicyclic HPK1 inhibitors2025
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-t2019
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tub2017
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tub2015
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tub2014
Quinolinone derivatives as PARP and tank inhibitors2014
Markers and diagnostic methods for metastasis2014
Quinolinone derivatives as PARP inhibitors2013
Quinolinone derivatives as PARP and TANK inhibitors2012
Quinazolinone derivatives as tubulin polymerization inhibitors2012
Method for the in vitro synthesis of short double stranded RNAs2010